Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Linear Diagnostics, a UK-based DNA diagnostics spinout of University of Birmingham, has obtained £2m ($2.6m) in a round involving the university and its medical diagnostics portfolio company Abingdon Health, SynbioBeta reported on Saturday. Venture capital firm Midven led the round leveraging funds from the UK government-backed Midlands Engine Investment Fund, with participation from the government-backed UK Innovation Science and Seed Fund (UKI2S) and undisclosed members of the Linear board. Founded in 2011, Linear Diagnostics has devised a handheld genetic diagnostics…
